Editorial Comment to Real‐world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan.

This document is an editorial comment published in the International Journal of Urology. It discusses the need for more data on the therapeutic benefits of third-line therapy, specifically with the use of EV, in real-world patients with advanced urothelial carcinoma (UC) in Japan. The authors state that the present data increase our knowledge about real-world practices regarding subsequent systemic therapy in Japanese patients with advanced UC. The authors are affiliated with the Department of Urology at Tokyo Women's Medical University in Tokyo, Japan. [Extracted from the article]